Copyright Reports & Markets. All rights reserved.

Global Nanoparticles in Biotechnology and Pharmaceuticals Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Nanoparticles in Biotechnology and Pharmaceuticals

      • 1.1 Definition of Nanoparticles in Biotechnology and Pharmaceuticals
      • 1.2 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Type
        • 1.2.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Fullerenes
        • 1.2.3 Liquid Crystals
        • 1.2.4 Liposomes
        • 1.2.5 Nanoshells
        • 1.2.6 Quantum dots
        • 1.2.7 Superparamagnetic nanoparticles
      • 1.3 Nanoparticles in Biotechnology and Pharmaceuticals Segment by Applications
        • 1.3.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Biotechnology
        • 1.3.3 Pharmaceutical
      • 1.4 Global Nanoparticles in Biotechnology and Pharmaceuticals Overall Market
        • 1.4.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue (2014-2025)
        • 1.4.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Production (2014-2025)
        • 1.4.3 North America Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)
        • 1.4.4 Europe Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)
        • 1.4.5 China Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)
        • 1.4.6 Japan Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)
        • 1.4.8 India Nanoparticles in Biotechnology and Pharmaceuticals Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Nanoparticles in Biotechnology and Pharmaceuticals
      • 2.3 Manufacturing Process Analysis of Nanoparticles in Biotechnology and Pharmaceuticals
      • 2.4 Industry Chain Structure of Nanoparticles in Biotechnology and Pharmaceuticals

      3 Development and Manufacturing Plants Analysis of Nanoparticles in Biotechnology and Pharmaceuticals

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Nanoparticles in Biotechnology and Pharmaceuticals
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Nanoparticles in Biotechnology and Pharmaceuticals Production and Capacity Analysis
      • 4.2 Nanoparticles in Biotechnology and Pharmaceuticals Revenue Analysis
      • 4.3 Nanoparticles in Biotechnology and Pharmaceuticals Price Analysis
      • 4.4 Market Concentration Degree

      5 Nanoparticles in Biotechnology and Pharmaceuticals Regional Market Analysis

      • 5.1 Nanoparticles in Biotechnology and Pharmaceuticals Production by Regions
        • 5.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production by Regions
        • 5.1.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Regions
      • 5.2 Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Regions
      • 5.3 North America Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.3.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.3.2 North America Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Nanoparticles in Biotechnology and Pharmaceuticals Import and Export
      • 5.4 Europe Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.4.1 Europe Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.4.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Nanoparticles in Biotechnology and Pharmaceuticals Import and Export
      • 5.5 China Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.5.1 China Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.5.2 China Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Nanoparticles in Biotechnology and Pharmaceuticals Import and Export
      • 5.6 Japan Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.6.1 Japan Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.6.2 Japan Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Nanoparticles in Biotechnology and Pharmaceuticals Import and Export
      • 5.7 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.7.1 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.7.2 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Import and Export
      • 5.8 India Nanoparticles in Biotechnology and Pharmaceuticals Market Analysis
        • 5.8.1 India Nanoparticles in Biotechnology and Pharmaceuticals Production
        • 5.8.2 India Nanoparticles in Biotechnology and Pharmaceuticals Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Nanoparticles in Biotechnology and Pharmaceuticals Import and Export

      6 Nanoparticles in Biotechnology and Pharmaceuticals Segment Market Analysis (by Type)

      • 6.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Production by Type
      • 6.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Revenue by Type
      • 6.3 Nanoparticles in Biotechnology and Pharmaceuticals Price by Type

      7 Nanoparticles in Biotechnology and Pharmaceuticals Segment Market Analysis (by Application)

      • 7.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption by Application
      • 7.2 Global Nanoparticles in Biotechnology and Pharmaceuticals Consumption Market Share by Application (2014-2019)

      8 Nanoparticles in Biotechnology and Pharmaceuticals Major Manufacturers Analysis

      • 8.1 Roche
        • 8.1.1 Roche Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.1.2 Roche Product Introduction, Application and Specification
        • 8.1.3 Roche Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GE Healthcare
        • 8.2.1 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.2.2 GE Healthcare Product Introduction, Application and Specification
        • 8.2.3 GE Healthcare Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 AMAG Pharmaceuticals
        • 8.5.1 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.5.2 AMAG Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 AMAG Pharmaceuticals Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Amgen
        • 8.6.1 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.6.2 Amgen Product Introduction, Application and Specification
        • 8.6.3 Amgen Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bausch & Lomb
        • 8.7.1 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.7.2 Bausch & Lomb Product Introduction, Application and Specification
        • 8.7.3 Bausch & Lomb Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Biogen
        • 8.8.1 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.8.2 Biogen Product Introduction, Application and Specification
        • 8.8.3 Biogen Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Celgene
        • 8.9.1 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.9.2 Celgene Product Introduction, Application and Specification
        • 8.9.3 Celgene Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Gilead
        • 8.10.1 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Production Sites and Area Served
        • 8.10.2 Gilead Product Introduction, Application and Specification
        • 8.10.3 Gilead Nanoparticles in Biotechnology and Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Ipsen
      • 8.12 Leadiant Biosciences
      • 8.13 nanoComposix
      • 8.14 Pacira Pharmaceuticals
      • 8.15 Pfizer
      • 8.16 Shire

      9 Development Trend of Analysis of Nanoparticles in Biotechnology and Pharmaceuticals Market

      • 9.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Trend Analysis
        • 9.1.1 Global Nanoparticles in Biotechnology and Pharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Nanoparticles in Biotechnology and Pharmaceuticals Regional Market Trend
        • 9.2.1 North America Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
        • 9.2.2 Europe Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
        • 9.2.3 China Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
        • 9.2.4 Japan Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
        • 9.2.5 Southeast Asia Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
        • 9.2.6 India Nanoparticles in Biotechnology and Pharmaceuticals Forecast 2019-2025
      • 9.3 Nanoparticles in Biotechnology and Pharmaceuticals Market Trend (Product Type)
      • 9.4 Nanoparticles in Biotechnology and Pharmaceuticals Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Nanoparticles in Biotechnology and Pharmaceuticals Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Nanoparticles are sub-nanosized colloidal structures composed of synthetic or semi-synthetic polymers. These are used in biotechnology and pharmaceutical sectors for studying biological systems for diagnosing diseases and focusing on treatment at the molecular level. The properties of many conventional materials alter when formed from nanoparticles, the reason being nanoparticles have a greater surface area per weight than larger particles, making them more reactive to other molecules
        The nanoparticle segment of the nanotechnology has wider application in pharmaceuticals such as in drug delivery and drug discovery, and in biotechnology such as in studying cellular dynamics and stem cell research. Nanotechnology is growing steadily supported by governments and technology firms making high investments in developing nanotechnology.
        Sedentary lifestyles and unbalanced diets, supported by the growing rate of urbanization, are consequent in increased widespread prevalence of chronic diseases. Chronic and lifestyle diseases such as cancer, heart diseases, stroke, chronic respiratory diseases, and diabetes. Nanoparticles are utilized to determine the biological alterations of peptide and protein fragments. This diagnosis aids in developing new treatment solutions to treat the growing incidences of chronic diseases. The increasing prevalence of chronic diseases is identified to be one of the key trends having a positive impact on the nanoparticles market in biotechnology and pharmaceutical sectors.

        The global Nanoparticles in Biotechnology and Pharmaceuticals market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Nanoparticles in Biotechnology and Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nanoparticles in Biotechnology and Pharmaceuticals market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Nanoparticles in Biotechnology and Pharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Nanoparticles in Biotechnology and Pharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Roche
        GE Healthcare
        Merck
        Novartis
        AMAG Pharmaceuticals
        Amgen
        Bausch & Lomb
        Biogen
        Celgene
        Gilead
        Ipsen
        Leadiant Biosciences
        nanoComposix
        Pacira Pharmaceuticals
        Pfizer
        Shire

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Fullerenes
        Liquid Crystals
        Liposomes
        Nanoshells
        Quantum dots
        Superparamagnetic nanoparticles

        Segment by Application
        Biotechnology
        Pharmaceutical

        Buy now